Travere Therapeutics, Inc.
Travere Therapeutics, Inc. (TVTX) Stock Overview
Explore Travere Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4B
P/E Ratio
-185.68
EPS (TTM)
$-0.50
ROE
-0.27%
TVTX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Travere Therapeutics, Inc. (TVTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 64.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $42.36.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -185.68 and a market capitalization of 4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.